Add To Watchlist
Share URL
About The Company
CEO
Ms. Karen Sue Lynch
Market Cap
84.54 Billion USD
Sector
Healthcare
Website
https://www.cvshealth.comLast Update
2/22/2024, 12:00:00 PM
Description
CVS Health Corporation provides health services in the United States.
Read More
Overview
Value
82
Growth
51
Health
41
Management
31
Analyst Opinion
91
Total
59
All Scores Out Of 100
Best Features
- Earnings growth has improved recently
- Has a low level of debt
- Price-to-earnings ratio of 11.4 is lower than the market average (19.6x)
- Has a margin-of-safety above fair value
- Liked by analysts
- Has strong dividend growth
Risk Factors
- There is a history of diluting shareholders
- Does not hold enough liquid assets to cover short term liabilities
- Disliked by Twitter users
- Very undervalued
Market Peers
CVS
Key Figures
PE Ratio (TTM)
11.45
Margin Of Safety (DCF)
204.60%
Revenue Growth (5 Year Average)
9.55%
Ratings Consensus
Strong Buy
Share Buybacks
-5.16%
Dividend Yeild (TTM)
3.35%
Valuation
Value Score
82
- ✔ Price-to-earnings ratio of 11.4 is lower than the market average (19.6x)
- ✔ Free-cashflow-yeild of 11.12% is better than the market average (4.7%)
- ✔ Margin-of-safety of 204.60% is better than the market average (17.95%)
- ✔ Estimated intrinsic-value of 226.32 USD is higher than current price ( 67.17 USD)
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 163.8 USD ✔
Current Price: 74.3 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
11.45x
Free Cashflow Yeild
11.12%
PE/Earnings Growth
N/A
Price/Book
1.22x
Growth
Growth Score
51
- ✔ Revenue growth has improved this yeara
- ✔ Earnings growth has improved this year
- ✔ 5 Year Average Cashflow growth of 16.65% is higher than the market average (12.35%)
- ✘ 5 Year Average Revenue growth of 9.55% is lower than the market average (10.97%)
- ✘ 5 Year Average Earnings growth of 8.27% is lower than the market average (14.48%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
9.55%
Earnings Growth
8.27%
Cashflow Growth
16.65%
Health
Health Score
41
Altman Z Score
2.22
Piostroski Score
6.00
Debt/Equity
1.00x
Current Assets/Liabilities
0.94x
Free Cashflow/Total Debt
0.19x
Debt/Capital
1.08x
Dividend
Secure Dividend Score
57
- ✔ Dividend yeild of 3.35% is more than the market average (1.85%)
- ✔ Dividend is likely safe
- ✔ Long term dividend payout ratio of -22.18% is considered good
- ✔ Payout ratio (TTM) of 37.54% is lower than the average (40%)
- ✔ Dividends have shown growth over the last 5 years
- ✘ Spending a higher percentage of their income on dividends than last 5 years
Dividend Yeild
3.35%
Dividend Growth
10.74%
Payout Ratio (Earnings)
37.54%
Payout Ratio (Cashflow)
30.13%
Management
Management Score
31
- ✔ Has returned higher dividends when earnings have risen
- ✘ Return-on-capital-employed of 2.65% is lower than the market average (10%)
- ✘ Has issued new shares whilst share price is low
- ✘ Has a history of diluting shareholders to finance activity
- ✘ Return-on-equity of 5.60% is lower than the market average (15%)
Average Buybacks/Dilution
-5.16%
Recent Buybacks/Dilution
-4.08%
5 Year Price Volitility
20.30%
Return On Assets
1.74%
Return On Capital Employed
2.65%
Return On Equity
5.60%
Return On Free Cashflow
N/A
Return On Investments
16.66%
Analysts
Analyst Opinion
91
- ✔ Ratings consensus is Strong Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
CVS Health Corporation
Currency
USD
Beta
0.604166
Vol Avg
8818042
Ceo
Ms. Karen Sue Lynch
Cik
0000064803
Cusip
126650100
Exchange
New York Stock Exchange
Full Time Employees
219000
Industry
Healthcare Plans
Sector
Healthcare
Ipo Date
1973-02-21
Address
One CVS Drive
City
Woonsocket
State
RI
Country
US
Zip
02895
Phone
401-765-1500
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
0
Twitter Sentiment
N/A
Stocktwits Sentiment
N/A